OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Genetic modification of inflammation- and clonal hematopoiesis–associated cardiovascular risk
Zhi Yu, Trevor P. Fidler, Yunfeng Ruan, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 18
Open Access | Times Cited: 33
Zhi Yu, Trevor P. Fidler, Yunfeng Ruan, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 18
Open Access | Times Cited: 33
Showing 1-25 of 33 citing articles:
Causes and consequences of clonal hematopoiesis
Lachelle D. Weeks, Benjamin L. Ebert
Blood (2023) Vol. 142, Iss. 26, pp. 2235-2246
Open Access | Times Cited: 40
Lachelle D. Weeks, Benjamin L. Ebert
Blood (2023) Vol. 142, Iss. 26, pp. 2235-2246
Open Access | Times Cited: 40
Genetic variation across and within individuals
Zhi Yu, Tim H. H. Coorens, Md Mesbah Uddin, et al.
Nature Reviews Genetics (2024) Vol. 25, Iss. 8, pp. 548-562
Closed Access | Times Cited: 19
Zhi Yu, Tim H. H. Coorens, Md Mesbah Uddin, et al.
Nature Reviews Genetics (2024) Vol. 25, Iss. 8, pp. 548-562
Closed Access | Times Cited: 19
Colchicine prevents accelerated atherosclerosis in TET2-mutant clonal haematopoiesis
María A. Zuriaga, Zhi Yu, Nuria Matesanz, et al.
European Heart Journal (2024)
Open Access | Times Cited: 15
María A. Zuriaga, Zhi Yu, Nuria Matesanz, et al.
European Heart Journal (2024)
Open Access | Times Cited: 15
Clonal Hematopoiesis Associates with Prevalent and Incident Cardiometabolic Disease in High-Risk Individuals
Jessica A. Regan, Lydia Coulter Kwee, Navid A. Nafissi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access | Times Cited: 1
Jessica A. Regan, Lydia Coulter Kwee, Navid A. Nafissi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access | Times Cited: 1
Suppression of IL-1β promotes beneficial accumulation of fibroblast-like cells in atherosclerotic plaques in clonal hematopoiesis
Trevor P. Fidler, Andrew Dunbar, Eunyoung Kim, et al.
Nature Cardiovascular Research (2024) Vol. 3, Iss. 1, pp. 60-75
Open Access | Times Cited: 10
Trevor P. Fidler, Andrew Dunbar, Eunyoung Kim, et al.
Nature Cardiovascular Research (2024) Vol. 3, Iss. 1, pp. 60-75
Open Access | Times Cited: 10
Clonal hematopoiesis and atherosclerosis
Ohad Oren, Aeron M. Small, Peter Libby
Journal of Clinical Investigation (2024) Vol. 134, Iss. 19
Closed Access | Times Cited: 8
Ohad Oren, Aeron M. Small, Peter Libby
Journal of Clinical Investigation (2024) Vol. 134, Iss. 19
Closed Access | Times Cited: 8
Haematometabolism rewiring in atherosclerotic cardiovascular disease
Laurent Yvan‐Charvet, Thibault Barouillet, Coraline Borowczyk
Nature Reviews Cardiology (2025)
Closed Access | Times Cited: 1
Laurent Yvan‐Charvet, Thibault Barouillet, Coraline Borowczyk
Nature Reviews Cardiology (2025)
Closed Access | Times Cited: 1
Clonal hematopoiesis of indeterminate potential as a prognostic factor: a systematic review and meta-analysis
Jasmine Singh, Nancy Li, Elham Ashrafi, et al.
Blood Advances (2024) Vol. 8, Iss. 14, pp. 3771-3784
Open Access | Times Cited: 7
Jasmine Singh, Nancy Li, Elham Ashrafi, et al.
Blood Advances (2024) Vol. 8, Iss. 14, pp. 3771-3784
Open Access | Times Cited: 7
Inflammatory profile of lower risk myelodysplastic syndromes
Joanne Topping, Adele M. Taylor, Fatima Nadat, et al.
British Journal of Haematology (2024) Vol. 205, Iss. 3, pp. 1044-1054
Open Access | Times Cited: 4
Joanne Topping, Adele M. Taylor, Fatima Nadat, et al.
British Journal of Haematology (2024) Vol. 205, Iss. 3, pp. 1044-1054
Open Access | Times Cited: 4
Hyosang Kwak, Ein Lee, Rajendra Karki
Immunological Reviews (2024)
Open Access | Times Cited: 4
Genomic Drivers of Coronary Artery Disease and Risk of Future Outcomes After Coronary Angiography
Kelvin Supriami, Sarah Urbut, José R. Tello-Ayala, et al.
JAMA Network Open (2025) Vol. 8, Iss. 1, pp. e2455368-e2455368
Open Access
Kelvin Supriami, Sarah Urbut, José R. Tello-Ayala, et al.
JAMA Network Open (2025) Vol. 8, Iss. 1, pp. e2455368-e2455368
Open Access
Genetic evidence for the causal effect of clonal hematopoiesis on pulmonary arterial hypertension
Jia-Yong Qiu, Shen-Shen Huang, Chao Liu, et al.
BMC Cardiovascular Disorders (2025) Vol. 25, Iss. 1
Open Access
Jia-Yong Qiu, Shen-Shen Huang, Chao Liu, et al.
BMC Cardiovascular Disorders (2025) Vol. 25, Iss. 1
Open Access
Bone Marrow Niche in Cardiometabolic Disease: Mechanisms and Therapeutic Potential
Zachary A. Kohutek, Heather L. Caslin, Daniel J. Fehrenbach, et al.
Circulation Research (2025) Vol. 136, Iss. 3, pp. 325-353
Closed Access
Zachary A. Kohutek, Heather L. Caslin, Daniel J. Fehrenbach, et al.
Circulation Research (2025) Vol. 136, Iss. 3, pp. 325-353
Closed Access
Clonal hematopoiesis of indeterminate potential, health indicators, and risk of cardiovascular diseases among patients with diabetes: a prospective cohort study
Ying Sun, Yuefeng Yu, Lingli Cai, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access
Ying Sun, Yuefeng Yu, Lingli Cai, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access
Roadmap for alleviating the manifestations of ageing in the cardiovascular system
Luca Liberale, Simon Tual‐Chalot, Simon Sedej, et al.
Nature Reviews Cardiology (2025)
Closed Access
Luca Liberale, Simon Tual‐Chalot, Simon Sedej, et al.
Nature Reviews Cardiology (2025)
Closed Access
Clonal hematopoiesis, cardiovascular disease and cancer treatment-induced cardiotoxicity
Nan Zhang, Xu Tian, Dong-Kun Sun, et al.
Seminars in Cancer Biology (2025)
Closed Access
Nan Zhang, Xu Tian, Dong-Kun Sun, et al.
Seminars in Cancer Biology (2025)
Closed Access
Inflammatory reprogramming of the solid tumor microenvironment by infiltrating clonal hematopoiesis is associated with adverse outcomes
Marco M. Buttigieg, Caitlyn Vlasschaert, Alexander G. Bick, et al.
Cell Reports Medicine (2025), pp. 101989-101989
Open Access
Marco M. Buttigieg, Caitlyn Vlasschaert, Alexander G. Bick, et al.
Cell Reports Medicine (2025), pp. 101989-101989
Open Access
The cytoplasmic sensor, the AIM2 inflammasome: A precise therapeutic target in vascular and metabolic diseases
Jiuguo Lin, Jiaojiao Wang, Jian Fang, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 12, pp. 1695-1719
Closed Access | Times Cited: 3
Jiuguo Lin, Jiaojiao Wang, Jian Fang, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 12, pp. 1695-1719
Closed Access | Times Cited: 3
Genetic and epigenetic regulation of inflammasomes: role in atherosclerosis
Mustafa Yalcınkaya, Alan R. Tall
Atherosclerosis (2024) Vol. 396, pp. 118541-118541
Closed Access | Times Cited: 3
Mustafa Yalcınkaya, Alan R. Tall
Atherosclerosis (2024) Vol. 396, pp. 118541-118541
Closed Access | Times Cited: 3
Effects of donor-engrafted clonal hematopoiesis in allogeneic and autologous stem cell transplantation: a systematic review and meta-analysis
Yiyu Xie, Vera Kazakova, Lachelle D. Weeks, et al.
Bone Marrow Transplantation (2024) Vol. 59, Iss. 11, pp. 1585-1593
Closed Access | Times Cited: 3
Yiyu Xie, Vera Kazakova, Lachelle D. Weeks, et al.
Bone Marrow Transplantation (2024) Vol. 59, Iss. 11, pp. 1585-1593
Closed Access | Times Cited: 3
Impact of Clonal Hematopoiesis–Associated Mutations in Phase I Patients Treated for Solid Tumors: An Analysis of the STING Trial
J.E. Rodriguez, Capucine Baldini, Arnaud Bayle, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 2
J.E. Rodriguez, Capucine Baldini, Arnaud Bayle, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 2
The Role of Clonal Hematopoiesis of Indeterminant Potential and DNA (Cytosine-5)-Methyltransferase Dysregulation in Pulmonary Arterial Hypertension and Other Cardiovascular Diseases
Isaac Emon, Ruaa Al‐Qazazi, Michael J. Rauh, et al.
Cells (2023) Vol. 12, Iss. 21, pp. 2528-2528
Open Access | Times Cited: 5
Isaac Emon, Ruaa Al‐Qazazi, Michael J. Rauh, et al.
Cells (2023) Vol. 12, Iss. 21, pp. 2528-2528
Open Access | Times Cited: 5
Inflammatory reprogramming of the tumor microenvironment by infiltrating clonal hematopoiesis is associated with adverse outcomes in solid cancer
Marco M. Buttigieg, Caitlyn Vlasschaert, Alexander G. Bick, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Marco M. Buttigieg, Caitlyn Vlasschaert, Alexander G. Bick, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Human Plasma Proteomic Profile of Clonal Hematopoiesis
Zhi Yu, Amélie Vromman, Ngoc Quynh Nguyen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Zhi Yu, Amélie Vromman, Ngoc Quynh Nguyen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
High cell-free DNA is associated with disease progression, inflammasome activation and elevated levels of inflammasome-related cytokine IL-18 in patients with myelofibrosis
Geraldine De Luca, Paola R. Lev, María Fernanda Camacho, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Geraldine De Luca, Paola R. Lev, María Fernanda Camacho, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
